Danny L’Ecluse retweeted
$ASML's stock is down 🔻26% over the past year and trading near a 1-year low. Meanwhile:
🔹 Revenue is up 28%
🔹 Free cash flow is up 238%
🔹 Holds $9 billion in cash
🔹 Maintains a monopoly position in the industry
Danny L’Ecluse retweeted
$GOOGL: a business with one of the largest user bases in the world, at a reasonable price👌
Danny L’Ecluse retweeted
$ASML: A compelling long-term investment at its current price👌
Danny L’Ecluse retweeted
#4 - Microsoft $MSFT: Combines AI cloud infrastructure with enterprise-grade software, making it indispensable to global businesses
Danny L’Ecluse retweeted
$ARGX #JPM25 slides
2025-26 catalysts
10 ph3, ensiprubart (C2i) now in ph3 (not a single-product company anymore soon) & more coming
argenx.com/content/dam/argen…
Danny L’Ecluse retweeted
Disruptive in our innovation mission, we are committed to pioneering transformative #immunology treatments. Vision 2030 embodies this commitment: reaching 50,000 patients across 10 indications by 2030.
#TogetherWeDiscover


























